Portfolio Companies 2026 for British Patient Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
British Patient Capital accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $2.1B. The median disclosed raise is $120M, and the largest is Quell Therapeutics at $344M, ahead of Tokamak Energy ($335M) and Quantum Motion ($251M).
The names that recur most often on these portfolio cap tables are British Patient Capital (15 companies), Sofinnova Partners (3 companies), Syncona (2 companies), UCL Technology Fund (2 companies), British Business Bank (2 companies), Oxford Science Enterprises (2 companies). By latest disclosed round, the market skews Series B (4), Series C (4), Series A (4), Series D (1).
Companies tracked: 14
Disclosed funding total: $2.1B across 14 companies
Median disclosed raise: $120M
Largest raise: Quell Therapeutics — $344M
Stage mix: Series B 4 · Series C 4 · Series A 4 · Series D 1